CLINICAL_TRIALS
trial_result
· 2016-02-24
Clinical Trial Update: A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer [Phase 3]
Summary
Phase 3 trial update of capecitabine (Xeloda) for metastatic colorectal cancer; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-02-24